Allyl Piperidine-1-Carbodiothioate And Benzyl 1h-Imidazole 1 Carbodithioate: Two Potential Agents To Combat Against Mycobacteria

Aims The emergence of multidrug resistant strains ofMycobacterium tuberculosishas made tuberculosis more difficult to manage clinically. With the aim of obtaining new and effective anti-mycobacterial agent(s), this study investigated the anti-mycobacterial activity of several imidazole and piperidine derivatives. Methods and Results Towards obtaining new anti-mycobacterial agents,Mycobacterium smegmatiscells were treated with different compounds for their growth inhibitory activity. Among these, benzyl 1H-imidazole-1-carbodithioate and allyl piperidine-1-carbodiothioate exhibited better inhibition than the others. Thereafter, anti-biofilm property of these two was examined by treatingM. smegmatiswith these agents before and after the formation of biofilm. The result showed that both the compounds at their sublethal dose inhibited the formation of biofilm as well as dispersed preformed biofilm. Consistently, they augmented the activity of isoniazid or rifampicin against biofilm-encapsulated cells. MTT assay was performed to examine the toxic effects of this combinatorial therapy on different cell lines. Results exhibited a low cytotoxicity for this combinatorial treatment. The activity of these two was also verified against dormant mycobacterial cells and was found to be effective. Conclusion The present study identified two compounds that exhibited anti-mycobacterial activities against both planktonic and dormant cells. These two also exhibited anti-biofilm activity at their sublethal dose and augmented the activity of isoniazid and rifampicin against biofilm encapsulated cells. Significance and Impact of the Study The current study provides two new agents that have the potential to be used in anti-mycobacterial therapy and may help in public health management.